Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Harold Swerdlow, George Komatsoulis, Juli Klemm, Daniel Bradbury, Robert Epstein, More

Premium

The New York Genome Center has appointed Harold Swerdlow as vice president of technology innovation. He joins NYGC from the Wellcome Trust Sanger Institute, where he was head of R&D. Prior to that, he was chief technology officer at Dolomite and senior director of research at Solexa.


George Komatsoulis has left the National Cancer Institute to work as a senior bioinformatics specialist at the National Center for Biotechnology Information.

Previously, he was the deputy director of the NCI's Center for Biomedical Informatics and
Information Technology (CBIIT). He's also served as acting chief information officer and interim director for CBIIT.

Juli Klemm is serving as acting deputy director for CBIIT while the agency searches for a replacement.


Illumina stockholders voted to re-elect four members of its board of directors, approving three-year terms on the board for Daniel Bradbury, Robert Epstein, and Roy Whitfield, and a two-year term for Francis deSouza.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.